background idiopathic pulmonary fibrosis act exacerb ipa constitute if devant event metres expect superimposed diffs alveolar damage unknown etiolog guideline recommend highs steroid treatment despite unproven benefit hypothesis previous immunosuppress administer adverse affect outcome method studi connect patient host depart if interior june protocol consist immer essay best support care broadspectrum antimicrobial thorough value detect revert caps followed survive postdischarg none receive result twentyfour admins fulfil criterion analyze unique event survive group previous treat where nine receive p never three history significantly influence greater compare immunosuppress survivor year concur apply mention half influence avoid may favor natur disease even moment 